EHMT2 and cholangiocarcinoma: Recently, Ma and co-workers presented evidence that the histone-lysine methyltransferase EHMT2 is up-regulated in human cholangiocarcinoma, which enhances cell growth and invasiveness by epigenetically silencing the Hippo pathway kinase large tumor suppressor 2 (LATS2) [44].